img

Global Urological Medications Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Urological Medications Market Insights, Forecast to 2034

Urological Medications are drugs used in the treatment of urogenital conditions and diseases such as SUI,BPH,OAB and ED.
Market Analysis and InsightsGlobal Urological Medications Market
The global Urological Medications market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Urological Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Urological Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Urological Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Urological Medications include Viatris, Pfizer, Merck, Astellas Pharma, Abbott, ADVANZ PHARMA, GlaxoSmithKline, Bayer HealthCare Pharmaceuticals and Novartis, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Urological Medications market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Urological Medications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Urological Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Urological Medications revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Urological Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Urological Medications revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Viatris, Pfizer, Merck, Astellas Pharma, Abbott, ADVANZ PHARMA, GlaxoSmithKline, Bayer HealthCare Pharmaceuticals and Novartis, etc.



By Company


Viatris
Pfizer
Merck
Astellas Pharma
Abbott
ADVANZ PHARMA
GlaxoSmithKline
Bayer HealthCare Pharmaceuticals
Novartis
Piramal Pharma Solutions
Endo International
Sanofi-aventis U.S. LLC
AbbVie
Mallinckrodt
Lilly
Segment by Type
Alpha Blockers
5-Alpha Inhibitors
Anticholinergics
Others

Segment by Application


SUI
BPH
OAB
ED
Prostate Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Urological Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Urological Medications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urological Medications revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urological Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Alpha Blockers
1.2.3 5-Alpha Inhibitors
1.2.4 Anticholinergics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Urological Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 SUI
1.3.3 BPH
1.3.4 OAB
1.3.5 ED
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urological Medications Market Perspective (2018-2034)
2.2 Global Urological Medications Growth Trends by Region
2.2.1 Urological Medications Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Urological Medications Historic Market Size by Region (2018-2024)
2.2.3 Urological Medications Forecasted Market Size by Region (2024-2034)
2.3 Urological Medications Market Dynamics
2.3.1 Urological Medications Industry Trends
2.3.2 Urological Medications Market Drivers
2.3.3 Urological Medications Market Challenges
2.3.4 Urological Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Urological Medications by Players
3.1.1 Global Urological Medications Revenue by Players (2018-2024)
3.1.2 Global Urological Medications Revenue Market Share by Players (2018-2024)
3.2 Global Urological Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Urological Medications, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Urological Medications Market Concentration Ratio
3.4.1 Global Urological Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urological Medications Revenue in 2022
3.5 Global Key Players of Urological Medications Head office and Area Served
3.6 Global Key Players of Urological Medications, Product and Application
3.7 Global Key Players of Urological Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Urological Medications Breakdown Data by Type
4.1 Global Urological Medications Historic Market Size by Type (2018-2024)
4.2 Global Urological Medications Forecasted Market Size by Type (2024-2034)
5 Urological Medications Breakdown Data by Application
5.1 Global Urological Medications Historic Market Size by Application (2018-2024)
5.2 Global Urological Medications Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Urological Medications Market Size (2018-2034)
6.2 North America Urological Medications Market Size by Type
6.2.1 North America Urological Medications Market Size by Type (2018-2024)
6.2.2 North America Urological Medications Market Size by Type (2024-2034)
6.2.3 North America Urological Medications Market Share by Type (2018-2034)
6.3 North America Urological Medications Market Size by Application
6.3.1 North America Urological Medications Market Size by Application (2018-2024)
6.3.2 North America Urological Medications Market Size by Application (2024-2034)
6.3.3 North America Urological Medications Market Share by Application (2018-2034)
6.4 North America Urological Medications Market Size by Country
6.4.1 North America Urological Medications Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Urological Medications Market Size by Country (2018-2024)
6.4.3 North America Urological Medications Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Urological Medications Market Size (2018-2034)
7.2 Europe Urological Medications Market Size by Type
7.2.1 Europe Urological Medications Market Size by Type (2018-2024)
7.2.2 Europe Urological Medications Market Size by Type (2024-2034)
7.2.3 Europe Urological Medications Market Share by Type (2018-2034)
7.3 Europe Urological Medications Market Size by Application
7.3.1 Europe Urological Medications Market Size by Application (2018-2024)
7.3.2 Europe Urological Medications Market Size by Application (2024-2034)
7.3.3 Europe Urological Medications Market Share by Application (2018-2034)
7.4 Europe Urological Medications Market Size by Country
7.4.1 Europe Urological Medications Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Urological Medications Market Size by Country (2018-2024)
7.4.3 Europe Urological Medications Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Urological Medications Market Size (2018-2034)
8.2 China Urological Medications Market Size by Type
8.2.1 China Urological Medications Market Size by Type (2018-2024)
8.2.2 China Urological Medications Market Size by Type (2024-2034)
8.2.3 China Urological Medications Market Share by Type (2018-2034)
8.3 China Urological Medications Market Size by Application
8.3.1 China Urological Medications Market Size by Application (2018-2024)
8.3.2 China Urological Medications Market Size by Application (2024-2034)
8.3.3 China Urological Medications Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Urological Medications Market Size (2018-2034)
9.2 Asia Urological Medications Market Size by Type
9.2.1 Asia Urological Medications Market Size by Type (2018-2024)
9.2.2 Asia Urological Medications Market Size by Type (2024-2034)
9.2.3 Asia Urological Medications Market Share by Type (2018-2034)
9.3 Asia Urological Medications Market Size by Application
9.3.1 Asia Urological Medications Market Size by Application (2018-2024)
9.3.2 Asia Urological Medications Market Size by Application (2024-2034)
9.3.3 Asia Urological Medications Market Share by Application (2018-2034)
9.4 Asia Urological Medications Market Size by Region
9.4.1 Asia Urological Medications Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Urological Medications Market Size by Region (2018-2024)
9.4.3 Asia Urological Medications Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Urological Medications Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Urological Medications Market Size by Type
10.2.1 Middle East, Africa, and Latin America Urological Medications Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Urological Medications Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Urological Medications Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Urological Medications Market Size by Application
10.3.1 Middle East, Africa, and Latin America Urological Medications Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Urological Medications Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Urological Medications Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Urological Medications Market Size by Country
10.4.1 Middle East, Africa, and Latin America Urological Medications Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Urological Medications Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Urological Medications Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Viatris
11.1.1 Viatris Company Details
11.1.2 Viatris Business Overview
11.1.3 Viatris Urological Medications Introduction
11.1.4 Viatris Revenue in Urological Medications Business (2018-2024)
11.1.5 Viatris Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Urological Medications Introduction
11.2.4 Pfizer Revenue in Urological Medications Business (2018-2024)
11.2.5 Pfizer Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Urological Medications Introduction
11.3.4 Merck Revenue in Urological Medications Business (2018-2024)
11.3.5 Merck Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Urological Medications Introduction
11.4.4 Astellas Pharma Revenue in Urological Medications Business (2018-2024)
11.4.5 Astellas Pharma Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Urological Medications Introduction
11.5.4 Abbott Revenue in Urological Medications Business (2018-2024)
11.5.5 Abbott Recent Developments
11.6 ADVANZ PHARMA
11.6.1 ADVANZ PHARMA Company Details
11.6.2 ADVANZ PHARMA Business Overview
11.6.3 ADVANZ PHARMA Urological Medications Introduction
11.6.4 ADVANZ PHARMA Revenue in Urological Medications Business (2018-2024)
11.6.5 ADVANZ PHARMA Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Urological Medications Introduction
11.7.4 GlaxoSmithKline Revenue in Urological Medications Business (2018-2024)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Bayer HealthCare Pharmaceuticals
11.8.1 Bayer HealthCare Pharmaceuticals Company Details
11.8.2 Bayer HealthCare Pharmaceuticals Business Overview
11.8.3 Bayer HealthCare Pharmaceuticals Urological Medications Introduction
11.8.4 Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2018-2024)
11.8.5 Bayer HealthCare Pharmaceuticals Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Urological Medications Introduction
11.9.4 Novartis Revenue in Urological Medications Business (2018-2024)
11.9.5 Novartis Recent Developments
11.10 Piramal Pharma Solutions
11.10.1 Piramal Pharma Solutions Company Details
11.10.2 Piramal Pharma Solutions Business Overview
11.10.3 Piramal Pharma Solutions Urological Medications Introduction
11.10.4 Piramal Pharma Solutions Revenue in Urological Medications Business (2018-2024)
11.10.5 Piramal Pharma Solutions Recent Developments
11.11 Endo International
11.11.1 Endo International Company Details
11.11.2 Endo International Business Overview
11.11.3 Endo International Urological Medications Introduction
11.11.4 Endo International Revenue in Urological Medications Business (2018-2024)
11.11.5 Endo International Recent Developments
11.12 Sanofi-aventis U.S. LLC
11.12.1 Sanofi-aventis U.S. LLC Company Details
11.12.2 Sanofi-aventis U.S. LLC Business Overview
11.12.3 Sanofi-aventis U.S. LLC Urological Medications Introduction
11.12.4 Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2018-2024)
11.12.5 Sanofi-aventis U.S. LLC Recent Developments
11.13 AbbVie
11.13.1 AbbVie Company Details
11.13.2 AbbVie Business Overview
11.13.3 AbbVie Urological Medications Introduction
11.13.4 AbbVie Revenue in Urological Medications Business (2018-2024)
11.13.5 AbbVie Recent Developments
11.14 Mallinckrodt
11.14.1 Mallinckrodt Company Details
11.14.2 Mallinckrodt Business Overview
11.14.3 Mallinckrodt Urological Medications Introduction
11.14.4 Mallinckrodt Revenue in Urological Medications Business (2018-2024)
11.14.5 Mallinckrodt Recent Developments
11.15 Lilly
11.15.1 Lilly Company Details
11.15.2 Lilly Business Overview
11.15.3 Lilly Urological Medications Introduction
11.15.4 Lilly Revenue in Urological Medications Business (2018-2024)
11.15.5 Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Urological Medications Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Alpha Blockers
Table 3. Key Players of 5-Alpha Inhibitors
Table 4. Key Players of Anticholinergics
Table 5. Key Players of Others
Table 6. Global Urological Medications Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Urological Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Urological Medications Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Urological Medications Market Share by Region (2018-2024)
Table 10. Global Urological Medications Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Urological Medications Market Share by Region (2024-2034)
Table 12. Urological Medications Market Trends
Table 13. Urological Medications Market Drivers
Table 14. Urological Medications Market Challenges
Table 15. Urological Medications Market Restraints
Table 16. Global Urological Medications Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Urological Medications Revenue Share by Players (2018-2024)
Table 18. Global Top Urological Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2022)
Table 19. Global Urological Medications Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Urological Medications Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Urological Medications, Headquarters and Area Served
Table 22. Global Key Players of Urological Medications, Product and Application
Table 23. Global Key Players of Urological Medications, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Urological Medications Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Urological Medications Revenue Market Share by Type (2018-2024)
Table 27. Global Urological Medications Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Urological Medications Revenue Market Share by Type (2024-2034)
Table 29. Global Urological Medications Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Urological Medications Revenue Share by Application (2018-2024)
Table 31. Global Urological Medications Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Urological Medications Revenue Share by Application (2024-2034)
Table 33. North America Urological Medications Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Urological Medications Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America Urological Medications Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Urological Medications Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America Urological Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America Urological Medications Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Urological Medications Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Urological Medications Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Urological Medications Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe Urological Medications Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Urological Medications Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe Urological Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe Urological Medications Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Urological Medications Market Size by Country (2024-2034) & (US$ Million)
Table 47. China Urological Medications Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Urological Medications Market Size by Type (2024-2034) & (US$ Million)
Table 49. China Urological Medications Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Urological Medications Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia Urological Medications Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Urological Medications Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia Urological Medications Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Urological Medications Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Urological Medications Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Urological Medications Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Urological Medications Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Urological Medications Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Urological Medications Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Urological Medications Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Urological Medications Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Urological Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America Urological Medications Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Urological Medications Market Size by Country (2024-2034) & (US$ Million)
Table 65. Viatris Company Details
Table 66. Viatris Business Overview
Table 67. Viatris Urological Medications Product
Table 68. Viatris Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 69. Viatris Recent Developments
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Urological Medications Product
Table 73. Pfizer Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 74. Pfizer Recent Developments
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Urological Medications Product
Table 78. Merck Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 79. Merck Recent Developments
Table 80. Astellas Pharma Company Details
Table 81. Astellas Pharma Business Overview
Table 82. Astellas Pharma Urological Medications Product
Table 83. Astellas Pharma Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 84. Astellas Pharma Recent Developments
Table 85. Abbott Company Details
Table 86. Abbott Business Overview
Table 87. Abbott Urological Medications Product
Table 88. Abbott Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 89. Abbott Recent Developments
Table 90. ADVANZ PHARMA Company Details
Table 91. ADVANZ PHARMA Business Overview
Table 92. ADVANZ PHARMA Urological Medications Product
Table 93. ADVANZ PHARMA Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 94. ADVANZ PHARMA Recent Developments
Table 95. GlaxoSmithKline Company Details
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Urological Medications Product
Table 98. GlaxoSmithKline Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 99. GlaxoSmithKline Recent Developments
Table 100. Bayer HealthCare Pharmaceuticals Company Details
Table 101. Bayer HealthCare Pharmaceuticals Business Overview
Table 102. Bayer HealthCare Pharmaceuticals Urological Medications Product
Table 103. Bayer HealthCare Pharmaceuticals Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 104. Bayer HealthCare Pharmaceuticals Recent Developments
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Urological Medications Product
Table 108. Novartis Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 109. Novartis Recent Developments
Table 110. Piramal Pharma Solutions Company Details
Table 111. Piramal Pharma Solutions Business Overview
Table 112. Piramal Pharma Solutions Urological Medications Product
Table 113. Piramal Pharma Solutions Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 114. Piramal Pharma Solutions Recent Developments
Table 115. Endo International Company Details
Table 116. Endo International Business Overview
Table 117. Endo International Urological Medications Product
Table 118. Endo International Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 119. Endo International Recent Developments
Table 120. Sanofi-aventis U.S. LLC Company Details
Table 121. Sanofi-aventis U.S. LLC Business Overview
Table 122. Sanofi-aventis U.S. LLC Urological Medications Product
Table 123. Sanofi-aventis U.S. LLC Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 124. Sanofi-aventis U.S. LLC Recent Developments
Table 125. AbbVie Company Details
Table 126. AbbVie Business Overview
Table 127. AbbVie Urological Medications Product
Table 128. AbbVie Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 129. AbbVie Recent Developments
Table 130. Mallinckrodt Company Details
Table 131. Mallinckrodt Business Overview
Table 132. Mallinckrodt Urological Medications Product
Table 133. Mallinckrodt Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 134. Mallinckrodt Recent Developments
Table 135. Lilly Company Details
Table 136. Lilly Business Overview
Table 137. Lilly Urological Medications Product
Table 138. Lilly Revenue in Urological Medications Business (2018-2024) & (US$ Million)
Table 139. Lilly Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urological Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Urological Medications Market Share by Type: 2022 VS 2034
Figure 3. Alpha Blockers Features
Figure 4. 5-Alpha Inhibitors Features
Figure 5. Anticholinergics Features
Figure 6. Others Features
Figure 7. Global Urological Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Urological Medications Market Share by Application: 2022 VS 2034
Figure 9. SUI Case Studies
Figure 10. BPH Case Studies
Figure 11. OAB Case Studies
Figure 12. ED Case Studies
Figure 13. Prostate Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Urological Medications Report Years Considered
Figure 16. Global Urological Medications Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Urological Medications Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Urological Medications Market Share by Region: 2022 VS 2034
Figure 19. Global Urological Medications Market Share by Players in 2022
Figure 20. Global Top Urological Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urological Medications as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Urological Medications Revenue in 2022
Figure 22. North America Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Urological Medications Market Share by Type (2018-2034)
Figure 24. North America Urological Medications Market Share by Application (2018-2034)
Figure 25. North America Urological Medications Market Share by Country (2018-2034)
Figure 26. United States Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Canada Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Europe Urological Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 29. Europe Urological Medications Market Share by Type (2018-2034)
Figure 30. Europe Urological Medications Market Share by Application (2018-2034)
Figure 31. Europe Urological Medications Market Share by Country (2018-2034)
Figure 32. Germany Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. France Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. U.K. Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Italy Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Russia Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Nordic Countries Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. China Urological Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 39. China Urological Medications Market Share by Type (2018-2034)
Figure 40. China Urological Medications Market Share by Application (2018-2034)
Figure 41. Asia Urological Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 42. Asia Urological Medications Market Share by Type (2018-2034)
Figure 43. Asia Urological Medications Market Share by Application (2018-2034)
Figure 44. Asia Urological Medications Market Share by Region (2018-2034)
Figure 45. Japan Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. South Korea Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. China Taiwan Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Southeast Asia Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. India Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Australia Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Urological Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Urological Medications Market Share by Type (2018-2034)
Figure 53. Middle East, Africa, and Latin America Urological Medications Market Share by Application (2018-2034)
Figure 54. Middle East, Africa, and Latin America Urological Medications Market Share by Country (2018-2034)
Figure 55. Brazil Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Mexico Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Turkey Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 59. Israel Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 60. GCC Countries Urological Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 61. Viatris Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 62. Pfizer Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 63. Merck Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 64. Astellas Pharma Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 65. Abbott Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 66. ADVANZ PHARMA Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 68. Bayer HealthCare Pharmaceuticals Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 69. Novartis Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 70. Piramal Pharma Solutions Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 71. Endo International Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 72. Sanofi-aventis U.S. LLC Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 73. AbbVie Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 74. Mallinckrodt Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 75. Lilly Revenue Growth Rate in Urological Medications Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries